D.A. Davidson & Co’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$508K Buy
54,120
+28,100
+108% +$264K ﹤0.01% 1051
2025
Q1
$185K Buy
26,020
+11,250
+76% +$80K ﹤0.01% 1332
2024
Q4
$172K Sell
14,770
-1,480
-9% -$17.3K ﹤0.01% 1353
2024
Q3
$334K Buy
16,250
+4,150
+34% +$85.3K ﹤0.01% 1151
2024
Q2
$271K Buy
+12,100
New +$271K ﹤0.01% 1202
2018
Q4
Sell
-10,166
Closed -$291K 1146
2018
Q3
$291K Sell
10,166
-8,729
-46% -$250K 0.01% 924
2018
Q2
$517K Sell
18,895
-324
-2% -$8.87K 0.01% 692
2018
Q1
$405K Buy
19,219
+2,395
+14% +$50.5K 0.01% 761
2017
Q4
$323K Buy
+16,824
New +$323K 0.01% 812